Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery

Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome: Multicentric Report

(2010) A. Gulati et al.   Clinical Journal of the American Society of Nephrology

Pediatric Idiopathic Nephrotic Syndrome: Treatment Strategies in Steroid Dependent and Steroid Resistant Forms

(2010) T. Ulinski et al.   CURRENT MEDICINAL CHEMISTRY

Rituximab efficiency in children with steroid-dependent nephrotic syndrome

(2010) Anne-Laure Sellier-Leclerc et al.   PEDIATRIC NEPHROLOGY

Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndrome

(2010) René Frydensbjerg Andersen et al.   PEDIATRIC NEPHROLOGY

Severe Ulcerative Colitis After Rituximab Therapy

(2010) D. S. Ardelean et al.   PEDIATRICS

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

(2009) Kenneth R Carson et al.   LANCET ONCOLOGY

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

(2009) Koichi Kamei et al.   PEDIATRIC NEPHROLOGY

Fatal pulmonary fibrosis after rituximab administration

(2009) Marie-Camille Chaumais et al.   PEDIATRIC NEPHROLOGY

Rituximab in refractory nephrotic syndrome

(2009) Agnieszka Prytuła et al.   PEDIATRIC NEPHROLOGY

Management of Childhood Onset Nephrotic Syndrome

(2009) D. S. Gipson et al.   PEDIATRICS

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

(2008) Vincent Guigonis et al.   PEDIATRIC NEPHROLOGY